Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,580
Total Claims
$825K
Drug Cost
935
Beneficiaries
$882
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,743 Pediatric Medicine providers
-15%
Opioid rate vs peers
1.3% vs 1.6% avg
-58%
Cost per patient vs peers
$882 vs $2,098 avg
-20%
Brand preference vs peers
12.1% vs 15.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.3%
Opioid Rate
129
Opioid Claims
$1,199
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,148 claims · $639K
Generic: 8,355 claims · $183K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 91 | $114K |
| Empagliflozin | 47 | $79K |
| Dulaglutide | 30 | $57K |
| Rivaroxaban | 26 | $43K |
| Semaglutide | 27 | $32K |
| Mirabegron | 25 | $31K |
| Sitagliptin Phosphate | 18 | $31K |
| Fluticasone/Umeclidin/Vilanter | 29 | $26K |
| Tirzepatide | 17 | $18K |
| Tiotropium Bromide | 20 | $13K |
| Icosapent Ethyl | 18 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $11K |
| Estrogens, Conjugated | 24 | $9,432 |
| Budesonide/Formoterol Fumarate | 19 | $8,764 |
| Levothyroxine Sodium | 582 | $8,630 |
Prescribing Profile
Patient Profile
75
Avg Age
66%
Female
1.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About